Home » PsychoGenics, AstraZeneca to Identify New Treatments for Central Nervous System Disorders
PsychoGenics, AstraZeneca to Identify New Treatments for Central Nervous System Disorders
PsychoGenics Inc. and AstraZeneca have entered into a drug discovery and development agreement to identify compounds that are likely to be useful for the treatment of certain Central Nervous System disorders.
Earth Times
Earth Times
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May